Braeburn is committed to the fight against opioid use disorder.
Opioid addiction, also known as opioid use disorder (OUD), is a medical condition requiring medical treatment. Together with counseling and support, Braeburn’s next generation medicines are developed with an aim to support patients with OUD as they focus on the reintegration of their lives and communities.
We are proud to be part of the solution in the fight against the opioid crisis.
Braeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid use disorder. We are committed to advancing next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of opioid use disorder faced by patients, healthcare professionals, payers and society.
Braeburn has one mission: to fight the opioid crisis. The work we are doing can make a difference in the lives of patients who often shoulder the burden of treatment themselves. We aim to reduce stigma by raising awareness that opioid use disorder (OUD) is a chronic brain disease best managed by evidence-based treatments.
These are unwavering and will pass the test of time.
What are our operating principles?
Our operating principles define how we work together to achieve our goals:
We value relationships with employees, patients, healthcare professionals, and advocacy organizations and commit to act responsibly in our interactions.
Braeburn is committed to conducting all Company business with integrity and according to the highest ethical standards. We value transparency and accountability. Our management team and board of directors are committed to honesty and compliance in all interactions with patients, advocacy organizations, business partners and healthcare professionals. We set high standards and are committed to maintaining a culture of ethical behavior and compliance.